Transcriptional profiling and pathway analysis of monosodium iodoacetate-induced experimental osteoarthritis in rats: relevance to human disease.
暂无分享,去创建一个
R. Head | J. Minnerly | D. Aguiar | S. Weinrich | R. Barve | P. Sullivan | R A Barve | J C Minnerly | D J Weiss | D M Meyer | D J Aguiar | P M Sullivan | S L Weinrich | R D Head | D. Weiss | D. Meyer
[1] D A Kalbhen,et al. Chemical model of osteoarthritis--a pharmacological evaluation. , 1987, The Journal of rheumatology.
[2] A. Bendele,et al. Spontaneous cartilage degeneration in guinea pigs. , 1988, Arthritis and rheumatism.
[3] J Dunham,et al. Structural and metabolic changes in articular cartilage induced by iodoacetate. , 1992, International journal of experimental pathology.
[4] H. Sumichika,et al. Sodium iodoacetate-induced experimental osteoarthritis and associated pain model in rats. , 2003, The Journal of veterinary medical science.
[5] Caimin Xu,et al. Microarray analysis of differential gene expression in temporomandibular joint condylar cartilage after experimentally induced osteoarthritis. , 2005, Osteoarthritis and cartilage.
[6] L. Lohmander,et al. The structure of aggrecan fragments in human synovial fluid. Evidence for the involvement in osteoarthritis of a novel proteinase which cleaves the Glu 373-Ala 374 bond of the interglobular domain. , 1992, The Journal of clinical investigation.
[7] L. Lohmander,et al. The structure of aggrecan fragments in human synovial fluid. Evidence that aggrecanase mediates cartilage degradation in inflammatory joint disease, joint injury, and osteoarthritis. , 1993, Arthritis and rheumatism.
[8] E. Grant,et al. Gene expression profiles: creating new perspectives in arthritis research. , 2002, Arthritis and rheumatism.
[9] K. Geoghegan,et al. Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. , 1996, The Journal of clinical investigation.
[10] K. Kuettner,et al. Prevalence of degenerative morphological changes in the joints of the lower extremity. , 1997, Osteoarthritis and cartilage.
[11] A. Bendele,et al. Induction of osteoarthritis in the rat by surgical tear of the meniscus: Inhibition of joint damage by a matrix metalloproteinase inhibitor. , 2002, Osteoarthritis and cartilage.
[12] G. Nuki,et al. Experimentally-induced osteoarthritis in the dog. , 1973, Annals of the rheumatic diseases.
[13] E. Myers,et al. Basic local alignment search tool. , 1990, Journal of molecular biology.
[14] A. Bendele,et al. Animal Models of Arthritis: Relevance to Human Disease , 1999, Toxicologic pathology.
[15] J. Pomonis,et al. Development and pharmacological characterization of a rat model of osteoarthritis pain , 2005, Pain.
[16] L. Kazis,et al. The prevalence of knee osteoarthritis in the elderly. The Framingham Osteoarthritis Study. , 1987, Arthritis and rheumatism.
[17] R. E. Guzman,et al. Weight bearing as a measure of disease progression and efficacy of anti-inflammatory compounds in a model of monosodium iodoacetate-induced osteoarthritis. , 2003, Osteoarthritis and cartilage.
[18] A. Gepstein,et al. Site specific changes in gene expression and cartilage metabolism during early experimental osteoarthritis. , 2004, Osteoarthritis and cartilage.
[19] L. Lohmander,et al. Metalloproteinases, tissue inhibitor, and proteoglycan fragments in knee synovial fluid in human osteoarthritis. , 1993, Arthritis and rheumatism.
[20] P. Gillet,et al. Mono-iodoacetate-induced experimental osteoarthritis: a dose-response study of loss of mobility, morphology, and biochemistry. , 1997, Arthritis and rheumatism.
[21] Bendele Am,et al. Animal models of osteoarthritis. , 2001 .
[22] M. J. Field,et al. The monosodium iodoacetate model of osteoarthritis: a model of chronic nociceptive pain in rats? , 2004, Neuroscience Letters.
[23] S. Kumar,et al. Human osteoarthritis synovial fluid and joint cartilage contain both aggrecanase- and matrix metalloproteinase-generated aggrecan fragments. , 2006, Osteoarthritis and cartilage.
[24] A Zien,et al. Anabolic and catabolic gene expression pattern analysis in normal versus osteoarthritic cartilage using complementary DNA-array technology. , 2001, Arthritis and rheumatism.
[25] E. Arner. Aggrecanase-mediated cartilage degradation. , 2002, Current opinion in pharmacology.
[26] A. Poole,et al. Detection of aggrecanase- and MMP-generated catabolic neoepitopes in the rat iodoacetate model of cartilage degeneration. , 2004, Osteoarthritis and cartilage.
[27] A. Freemont,et al. Moderation of iodoacetate-induced experimental osteoarthritis in rats by matrix metalloproteinase inhibitors. , 2001, Osteoarthritis and cartilage.
[28] R. Moskowitz,et al. Experimentally induced degenerative joint lesions following partial meniscectomy in the rabbit. , 1973, Arthritis and rheumatism.
[29] R. E. Guzman,et al. Mono-Iodoacetate-Induced Histologic Changes in Subchondral Bone and Articular Cartilage of Rat Femorotibial Joints: An Animal Model of Osteoarthritis , 2003, Toxicologic pathology.